DE10028837A1 - Verfahren zum Nachweis von Influenza A/B-Viren - Google Patents

Verfahren zum Nachweis von Influenza A/B-Viren

Info

Publication number
DE10028837A1
DE10028837A1 DE10028837A DE10028837A DE10028837A1 DE 10028837 A1 DE10028837 A1 DE 10028837A1 DE 10028837 A DE10028837 A DE 10028837A DE 10028837 A DE10028837 A DE 10028837A DE 10028837 A1 DE10028837 A1 DE 10028837A1
Authority
DE
Germany
Prior art keywords
influenza
saliva
detection
virus
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE10028837A
Other languages
German (de)
English (en)
Inventor
Juergen Klepp
Reiner Schlipfenbacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7645396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10028837(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority to DE10028837A priority Critical patent/DE10028837A1/de
Priority to AT01956475T priority patent/ATE385259T1/de
Priority to JP2002510708A priority patent/JP2004503248A/ja
Priority to CA002412121A priority patent/CA2412121C/en
Priority to US10/311,523 priority patent/US6811971B2/en
Priority to AU2001278452A priority patent/AU2001278452A1/en
Priority to PCT/EP2001/006735 priority patent/WO2001096595A2/de
Priority to ES01956475.6T priority patent/ES2298244T5/es
Priority to DE50113548T priority patent/DE50113548D1/de
Priority to EP01956475.6A priority patent/EP1297187B2/de
Publication of DE10028837A1 publication Critical patent/DE10028837A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE10028837A 2000-06-15 2000-06-15 Verfahren zum Nachweis von Influenza A/B-Viren Ceased DE10028837A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE10028837A DE10028837A1 (de) 2000-06-15 2000-06-15 Verfahren zum Nachweis von Influenza A/B-Viren
EP01956475.6A EP1297187B2 (de) 2000-06-15 2001-06-15 Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
US10/311,523 US6811971B2 (en) 2000-06-15 2001-06-15 Method for the detection of influenza A/B viruses
JP2002510708A JP2004503248A (ja) 2000-06-15 2001-06-15 インフルエンザａウイルスおよび／またはインフルエンザｂウイルスの検出方法
CA002412121A CA2412121C (en) 2000-06-15 2001-06-15 Method for the detection of influenza a/b viruses
AT01956475T ATE385259T1 (de) 2000-06-15 2001-06-15 Verfahren zum nachweis von influenza a/b-viren in speichel
AU2001278452A AU2001278452A1 (en) 2000-06-15 2001-06-15 Method for the detection of influenza a/b viruses
PCT/EP2001/006735 WO2001096595A2 (de) 2000-06-15 2001-06-15 Verfahren zum nachweis von influenza a/b-viren aus speichel
ES01956475.6T ES2298244T5 (es) 2000-06-15 2001-06-15 Método para la detección de los virus de la gripe A/B en saliva
DE50113548T DE50113548D1 (de) 2000-06-15 2001-06-15 Verfahren zum Nachweis von Influenza A/B-Viren in Speichel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10028837A DE10028837A1 (de) 2000-06-15 2000-06-15 Verfahren zum Nachweis von Influenza A/B-Viren

Publications (1)

Publication Number Publication Date
DE10028837A1 true DE10028837A1 (de) 2001-12-20

Family

ID=7645396

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10028837A Ceased DE10028837A1 (de) 2000-06-15 2000-06-15 Verfahren zum Nachweis von Influenza A/B-Viren
DE50113548T Expired - Lifetime DE50113548D1 (de) 2000-06-15 2001-06-15 Verfahren zum Nachweis von Influenza A/B-Viren in Speichel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50113548T Expired - Lifetime DE50113548D1 (de) 2000-06-15 2001-06-15 Verfahren zum Nachweis von Influenza A/B-Viren in Speichel

Country Status (9)

Country Link
US (1) US6811971B2 (https=)
EP (1) EP1297187B2 (https=)
JP (1) JP2004503248A (https=)
AT (1) ATE385259T1 (https=)
AU (1) AU2001278452A1 (https=)
CA (1) CA2412121C (https=)
DE (2) DE10028837A1 (https=)
ES (1) ES2298244T5 (https=)
WO (1) WO2001096595A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057605A3 (en) * 2006-11-10 2008-07-17 Quidel Corp Nuclear protein extraction medium and method of use
WO2009142742A1 (en) * 2008-05-20 2009-11-26 Cantimer, Inc. Methods, systems and devices for analyzing a biological fluid sample following ion exchange

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275173A1 (en) * 2002-09-25 2004-04-19 Board Of Regents, The University Of Texas System Endogenous granzyme b in human non-hematopoietic cells
WO2006121773A2 (en) * 2005-05-06 2006-11-16 Gen-Probe Incorporated Compositions and assays to detect influenza virus a and b nucleic acids
AU2007217765A1 (en) * 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
US20080208486A1 (en) * 2006-03-23 2008-08-28 Jari Natunen Integrated System, Device and Use Thereof
US20070238095A1 (en) * 2006-04-11 2007-10-11 Mayo Foundation For Medical Education And Research , A Minnesota Corporation Detection of Influenza A Virus
US20070238093A1 (en) * 2006-04-11 2007-10-11 Espy Mark J Detection of influenza A virus
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
FI20060946A0 (fi) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
WO2008128095A1 (en) * 2007-04-12 2008-10-23 Regents Of The University Of Minnesota Ischemia/reperfusion protection compositions and methods of using
EP2716656B1 (en) 2007-06-15 2016-10-12 Xiamen University Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
US9689031B2 (en) 2007-07-14 2017-06-27 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (en) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
US20110046001A1 (en) * 2007-11-20 2011-02-24 Autogenomics, Inc. Multiplex Assay for Respiratory Viruses
US8354230B2 (en) 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
US20110045458A1 (en) * 2009-08-20 2011-02-24 Mayo Foundation For Medical Education And Research Detection of Enterovirus
KR101919330B1 (ko) 2011-06-16 2018-11-19 후지필름 가부시키가이샤 고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
GB201703383D0 (en) 2017-03-02 2017-04-19 Gargle Tech Ltd Testing for particulates
EP4205851A3 (en) 2018-09-05 2023-10-04 Hero Scientific Ltd Testing for particulates
CN112204372A (zh) * 2018-11-08 2021-01-08 松下知识产权经营株式会社 检测系统以及信息显示系统
CN113167763A (zh) 2018-12-04 2021-07-23 株式会社村田制作所 病毒检测系统、病毒检测方法以及病毒检测程序
US11053531B2 (en) 2019-05-31 2021-07-06 Linda Marie Petter Tester paper and methods of use thereof for detecting a bacterial infection
US12449336B2 (en) 2020-03-11 2025-10-21 Hero Scientific Ltd. Testing devices
EP4165385B1 (en) 2021-01-06 2024-04-17 Hero Scientific Ltd Filtration sampling devices
US20240302370A1 (en) * 2021-02-12 2024-09-12 Siemens Healthcare Diagnostics Inc. Sample lysis reagent compositions and methods of production and use thereof
US12529707B2 (en) * 2021-07-22 2026-01-20 Assaya Llc Lateral flow assay machine testing quality verification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131504T2 (de) 1990-12-31 1999-11-18 Oklahoma Medical Research Foundation, Oklahoma Verfahren zum visuellen nachweis der anwesenheit eines virus in einer klinischen probe
FR2708348B1 (fr) 1993-07-28 1995-10-06 Stago Diagnostica Procédé de dosage d'une substance immunologique au moyen de particules de latex magnétiques et de particules non-magnétiques.
US5714341A (en) * 1994-03-30 1998-02-03 Epitope, Inc. Saliva assay method and device
US6015664A (en) 1995-11-03 2000-01-18 Mcw Research Foundation Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B
EP1010981A1 (de) 1998-12-18 2000-06-21 Diagor GmbH Konjugate zum Nachweis von Viren und deren Verwendung

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057605A3 (en) * 2006-11-10 2008-07-17 Quidel Corp Nuclear protein extraction medium and method of use
WO2009142742A1 (en) * 2008-05-20 2009-11-26 Cantimer, Inc. Methods, systems and devices for analyzing a biological fluid sample following ion exchange
US8426207B2 (en) 2008-05-20 2013-04-23 Cantimer, Inc. Methods, systems and devices for analyzing a biological fluid sample following ion exchange

Also Published As

Publication number Publication date
DE50113548D1 (de) 2008-03-20
WO2001096595A2 (de) 2001-12-20
EP1297187B2 (de) 2014-08-13
ES2298244T5 (es) 2014-11-14
CA2412121A1 (en) 2002-12-09
US20030143530A1 (en) 2003-07-31
US6811971B2 (en) 2004-11-02
CA2412121C (en) 2009-09-01
JP2004503248A (ja) 2004-02-05
EP1297187B1 (de) 2008-01-30
AU2001278452A1 (en) 2001-12-24
ES2298244T3 (es) 2008-05-16
EP1297187A2 (de) 2003-04-02
ATE385259T1 (de) 2008-02-15
WO2001096595A3 (de) 2002-05-23

Similar Documents

Publication Publication Date Title
EP1297187B1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
Suleman et al. Point of care detection of COVID-19: Advancement in biosensing and diagnostic methods
Smith et al. The incidence of Herpesvirus hominis antibody in the population
World Health Organization WHO manual on animal influenza diagnosis and surveillance
DE3882705T2 (de) Immunoglobulin-bestimmungsverfahren.
Spira et al. Micromethod for assaying reverse transcriptase of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus
Lohr et al. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes
DE202020105116U1 (de) Reagenzien und Verwendungen zur Diagnose einer SARS-CoV-2-Infektion
DE69518697T2 (de) Nachweis von Treponema Pallidum und Haemophilus Ducreyi
CN102337351A (zh) 一种流感病毒分型检测试剂盒
DE202020105117U1 (de) Reagenzien und Verwendungen zur Diagnose einer SARS-CoV-2-Infektion
DE69008743T2 (de) Extraktionszusammensetzung, Testsatz und deren Verwendung zum Nachweis von Herpes-Simplex-Antigen.
Biber et al. The role of mouthwash sampling in SARS-CoV-2 diagnosis
JP5198710B2 (ja) 免疫学的測定方法
EP0769954B1 (de) Qualitätsgesichertes arzneimittel, enthaltend ein oder mehrere plasmaderivate
Henriques et al. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors
DE60218321T2 (de) Nachweis des virus der viralen rinderdiarrhoe in gewebsproben
DE2521460C2 (de) Verfahren zum Nachweis von Antikörpern gegen Brucella canis und Antigenreagens
Hegazy et al. Comparative evaluation of some techniques used for the detection of rabies virus
EP0707635A1 (de) Verfahren zum direkten und biochemisch funktionellen nachweis von retroviren in biologischen proben
Leparc et al. Search for poliovirus in specimens from patients with the post‐polio syndrome
Arborio et al. Diagnosis of a human case of Rift Valley fever by immunoperoxidase demonstration of antigen in fixed liver tissue
Carlisle et al. A multicentre study comparing post-mortem SARS-CoV-2 antibody testing in Cape Town mortuaries
CN106153926A (zh) 乙型脑炎病毒IgG抗体检测试剂盒及其制备方法
EP0800084A1 (de) Technik zum Nachweis von Infektionen mit dem TBE-Virus und anderen Flaviviren

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection